Experiment: 7WNR

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.4 mM [U-99% 15N] nMazE6, 20 mM NA potassium phosphate, 20 mM NA sodium chloride, 1 mM NA EDTA, 0.01 % NA sodium azide, 0.2 mM NA DSS, 10 % [U-99% 2H] D2O	90% H2O/10% D2O	100 mM	7	1 atm	298	Agilent Agilent DDS2 600MHz 600
2	3D HNCACB	0.4 mM [U-99% 13C; U-99% 15N] nMazE6, 20 mM NA potassium phosphate, 20 mM NA sodium chloride, 1 mM NA EDTA, 0.01 % NA sodium azide, 0.2 mM NA DSS, 10 % [U-99% 2H] D2O	90% H2O/10% D2O	100 mM	7	1 atm	298	Agilent Agilent DDS2 600MHz 600
3	3D CC(CO)NH	0.4 mM [U-99% 13C; U-99% 15N] nMazE6, 20 mM NA potassium phosphate, 20 mM NA sodium chloride, 1 mM NA EDTA, 0.01 % NA sodium azide, 0.2 mM NA DSS, 10 % [U-99% 2H] D2O	90% H2O/10% D2O	100 mM	7	1 atm	298	Agilent Agilent DDS2 600MHz 600
4	3D HNCO	0.4 mM [U-99% 13C; U-99% 15N] nMazE6, 20 mM NA potassium phosphate, 20 mM NA sodium chloride, 1 mM NA EDTA, 0.01 % NA sodium azide, 0.2 mM NA DSS, 10 % [U-99% 2H] D2O	90% H2O/10% D2O	100 mM	7	1 atm	298	Agilent Agilent DDS2 600MHz 600
5	3D HN(CA)CO	0.4 mM [U-99% 13C; U-99% 15N] nMazE6, 20 mM NA potassium phosphate, 20 mM NA sodium chloride, 1 mM NA EDTA, 0.01 % NA sodium azide, 0.2 mM NA DSS, 10 % [U-99% 2H] D2O	90% H2O/10% D2O	100 mM	7	1 atm	298	Agilent Agilent DDS2 600MHz 600
6	3D H(CCO)NH	0.4 mM [U-99% 13C; U-99% 15N] nMazE6, 20 mM NA potassium phosphate, 20 mM NA sodium chloride, 1 mM NA EDTA, 0.01 % NA sodium azide, 0.2 mM NA DSS, 10 % [U-99% 2H] D2O	90% H2O/10% D2O	100 mM	7	1 atm	298	Agilent Agilent DDS2 600MHz 600
7	2D 1H-1H TOCSY	0.4 mM NA nMazE6, 20 mM NA potassium phosphate, 20 mM NA sodium chloride, 1 mM NA EDTA, 0.01 % NA sodium azide, 0.2 mM NA DSS, 10 % [U-99% 2H] D2O	90% H2O/10% D2O	100 mM	7	1 atm	298	Agilent Agilent DDS2 600MHz 600
8	2D 1H-1H NOESY	0.4 mM NA nMazE6, 20 mM NA potassium phosphate, 20 mM NA sodium chloride, 1 mM NA EDTA, 0.01 % NA sodium azide, 0.2 mM NA DSS, 10 % [U-99% 2H] D2O	90% H2O/10% D2O	100 mM	7	1 atm	298	Agilent Agilent DDS2 600MHz 600
9	13C, 15N simultaneousEdited NOESY	0.4 mM [U-99% 13C; U-99% 15N] nMazE6, 20 mM NA potassium phosphate, 20 mM NA sodium chloride, 1 mM NA EDTA, 0.01 % NA sodium azide, 0.2 mM NA DSS, 10 % [U-99% 2H] D2O	90% H2O/10% D2O	100 mM	7	1 atm	298	Agilent Agilent DDS2 600MHz 600
10	3D HCCH-TOCSY	0.4 mM [U-99% 13C; U-99% 15N] nMazE6, 20 mM NA potassium phosphate, 20 mM NA sodium chloride, 1 mM NA EDTA, 0.01 % NA sodium azide, 0.2 mM NA DSS, 10 % [U-99% 2H] D2O	90% H2O/10% D2O	100 mM	7	1 atm	298	Agilent Agilent DDS2 600MHz 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Agilent	Agilent DDS2 600MHz	600

NMR Refinement
Method	Details	Software
DGSA-distance geometry simulated annealing		HADDOCK

NMR Ensemble Information
Conformer Selection Criteria	structures with favorable non-bond energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	4
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VnmrJ	4.2	Agilent
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	CcpNmr Analysis		CCPN
4	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
5	refinement	X-PLOR NIH	3.1	Schwieters, Kuszewski, Tjandra and Clore
6	structure calculation	HADDOCK		Bonvin

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.